Compare Adaptive Biotechnologies Corp (ADPT) vs HSBC Holdings plc (HSBC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs HSBC Holdings plc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while HSBC Holdings plc trades at $103.85 (market cap $353.82B). The key difference: HSBC Holdings plc is far larger — about 87.6× Adaptive Biotechnologies Corp's market cap, and HSBC Holdings plc pays a 3.63% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | HSBC | |
|---|---|---|
Market Cap | $4.04B | $353.82B |
Sector | Health | Technology |
52-Week High | $25.45 | $107.86 |
52-Week Low | $12.30 | $63.84 |
Enterprise Value | $4.10B | — |
Dividend Yield | — | 3.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About HSBC Holdings plc
HSBC is one of the world's largest banking and financial services organizations. It serves customers worldwide through four global businesses: Retail, Commercial, Global Banking, and Private Banking.
Read more on HSBC →
